These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6979417

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA, Heywood SN, Laughton E, Gould JJ, Freestone DS.
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR, Schneider F, Muller CP.
    Vaccine; 2006 Mar 24; 24(14):2594-601. PubMed ID: 16427163
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
    Al-Nakib W, Best JM, Banatvala JE.
    Clin Exp Immunol; 1975 Nov 24; 22(2):293-301. PubMed ID: 813933
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Rubella seroconversion following immunization in a rural practice.
    Hough JC, Walker RB, Brough JW.
    J Fam Pract; 1979 Oct 24; 9(4):587-9. PubMed ID: 479785
    [Abstract] [Full Text] [Related]

  • 31. Susceptibility to rubella and borderline immunity.
    Fogel A, Barnea B, Gerichter CB.
    Isr J Med Sci; 1983 Oct 24; 19(10):934-5. PubMed ID: 6363349
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Factors associated with clinical reactions to rubella vaccination in women.
    Nakazono N, Fujimoto S, Wakisaka A, Ishii K, Ichinoe K, Aizawa M.
    Int J Gynaecol Obstet; 1987 Jun 24; 25(3):207-16. PubMed ID: 2886379
    [Abstract] [Full Text] [Related]

  • 37. Rubella antibody titres and immunization status in a family practice.
    Mills DA, Parker KR, Evans CE.
    Can Med Assoc J; 1980 Mar 08; 122(5):549-52. PubMed ID: 7370858
    [Abstract] [Full Text] [Related]

  • 38. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine.
    LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ.
    J Infect Dis; 2009 Sep 15; 200(6):888-99. PubMed ID: 19659440
    [Abstract] [Full Text] [Related]

  • 39. [An observation of the immuno-persistence after inoculating with the domestic BRD II strain rubella vaccine among infants and young children].
    Xu A, Song L, Wang C, Wang A, Xu Q, Xiao Z, Wang S, Li M, Hao S, Li Z.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr 15; 21(2):117-20. PubMed ID: 11860770
    [Abstract] [Full Text] [Related]

  • 40. [Immune protection against rubella in a group of women in Latium].
    Fischetti M, Melino C, Venza F.
    Clin Ter; 1991 Feb 15; 136(3):173-8. PubMed ID: 1827380
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.